Quantitative Systematic Strategies’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Quantitative Systematic Strategies’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,751	Closed	-$204K	–	628
2019 Q4	$204K	Sell	3,751 -4,613	-55%	-$228K	0.03%	500
2019 Q3	$349K	Buy	+8,364	New	+$353K	0.08%	307
2018 Q3	–	Sell	-5,183	Closed	-$205K	–	900
2018 Q2	$205K	Buy	+5,183	New	+$164K	0.04%	553

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Quantitative Systematic Strategies's BHVN Position: Q1 2020 in Review

Quantitative Systematic Strategies sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2020, closing a stake of 3,751 shares — an estimated $204K sold.

Quantitative Systematic Strategies first reported a position in BHVN in Q2 2018 and held it in 3 quarters. The position peaked at $349K in Q3 2019. 175 funds tracked by Wall St. Rank hold BHVN as of Q1 2020.

Quantitative Systematic Strategies reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2020 after selling out during the quarter.
Quantitative Systematic Strategies sold 3,751 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2020, an estimated $204K.
Quantitative Systematic Strategies first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2018 and held it in 3 quarters.
Quantitative Systematic Strategies's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $349K in Q3 2019.
175 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2020, filed 6 May 2020.